Jump Financial’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-60,363
Closed -$3.05M 2346
2023
Q2
$3.05M Buy
60,363
+1,075
+2% +$57.2K 0.11% 247
2023
Q1
$3.23M Buy
59,288
+27,388
+86% +$1.6M 0.13% 244
2022
Q4
$1.99M Sell
31,900
-13,800
-30% -$916K 0.1% 266
2022
Q3
$3.22M Buy
+45,700
New +$3.15M 0.13% 235
2021
Q4
Sell
-5,663
Closed -$369K 1792
2021
Q3
$369K Sell
5,663
-5,516
-49% -$376K 0.03% 579
2021
Q2
$709K Buy
+11,179
New +$660K 0.07% 363
2021
Q1
Sell
-6,299
Closed -$314K 1366
2020
Q4
$314K Sell
6,299
-13,001
-67% -$610K 0.05% 574
2020
Q3
$985K Buy
+19,300
New +$806K 0.2% 122

Other funds holding AXNX

Jump Financial's AXNX Position: Q3 2023 in Review

Jump Financial sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 60,363 shares — an estimated $3.05M sold.

Jump Financial first reported a position in AXNX in Q3 2020 and held it in 8 quarters. The position peaked at $3.23M in Q1 2023. 221 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

  • Jump Financial reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Jump Financial sold 60,363 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $3.05M.
  • Jump Financial first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Jump Financial's Axonics, Inc. Common Stock position peaked at $3.23M in Q1 2023.
  • 221 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Jump Financial's 13F filing for Q3 2023, filed 7 Nov 2023.